Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA.
Publication
, Journal Article
Rasmussen, RV; Fowler, VG; Skov, R; Bruun, NE
Published in: Future Microbiol
January 2011
Staphylococcus aureus bacteremia (SAB) is an urgent medical problem due to its growing frequency and its poor associated outcome. As healthcare delivery increasingly involves invasive procedures and implantable devices, the number of patients at risk for SAB and its complications is likely to grow. Compounding this problem is the growing prevalence of methicillin-resistant S. aureus (MRSA) and the dwindling efficacy of vancomycin, long the treatment of choice for this pathogen. Despite the recent availability of several new antibiotics for S. aureus, new strategies for treatment and prevention are required for this serious, common cause of human infection.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Future Microbiol
DOI
EISSN
1746-0921
Publication Date
January 2011
Volume
6
Issue
1
Start / End Page
43 / 56
Location
England
Related Subject Headings
- Vancomycin
- Staphylococcal Infections
- Microbiology
- Methicillin-Resistant Staphylococcus aureus
- Livestock
- Humans
- Endocarditis
- Cross Infection
- Bacteremia
- Anti-Bacterial Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Rasmussen, R. V., Fowler, V. G., Skov, R., & Bruun, N. E. (2011). Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol, 6(1), 43–56. https://doi.org/10.2217/fmb.10.155
Rasmussen, Rasmus V., Vance G. Fowler, Robert Skov, and Niels E. Bruun. “Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA.” Future Microbiol 6, no. 1 (January 2011): 43–56. https://doi.org/10.2217/fmb.10.155.
Rasmussen RV, Fowler VG, Skov R, Bruun NE. Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol. 2011 Jan;6(1):43–56.
Rasmussen, Rasmus V., et al. “Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA.” Future Microbiol, vol. 6, no. 1, Jan. 2011, pp. 43–56. Pubmed, doi:10.2217/fmb.10.155.
Rasmussen RV, Fowler VG, Skov R, Bruun NE. Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol. 2011 Jan;6(1):43–56.
Published In
Future Microbiol
DOI
EISSN
1746-0921
Publication Date
January 2011
Volume
6
Issue
1
Start / End Page
43 / 56
Location
England
Related Subject Headings
- Vancomycin
- Staphylococcal Infections
- Microbiology
- Methicillin-Resistant Staphylococcus aureus
- Livestock
- Humans
- Endocarditis
- Cross Infection
- Bacteremia
- Anti-Bacterial Agents